$NEPH
NEPHROS INC

2013 Q3 Form 10-Q Financial Statement

#000114420413045172 Filed on August 13, 2013

View on sec.gov

Income Statement

Concept 2013 Q3 2013 Q2 2012 Q2
Revenue $418.0K $575.0K $302.0K
YoY Change -30.79% 90.4% -52.81%
Cost Of Revenue $189.0K $226.0K $35.00K
YoY Change -1.05% 545.71% -91.86%
Gross Profit $229.0K $349.0K $267.0K
YoY Change -44.55% 30.71% 33.5%
Gross Profit Margin 54.78% 60.7% 88.41%
Selling, General & Admin $578.0K $660.0K $838.0K
YoY Change -42.54% -21.24% 26.97%
% of Gross Profit 252.4% 189.11% 313.86%
Research & Development $204.0K $259.0K $199.0K
YoY Change -1.92% 30.15% 65.83%
% of Gross Profit 89.08% 74.21% 74.53%
Depreciation & Amortization $0.00 $10.00K $40.00K
YoY Change -100.0% -75.0% 33.33%
% of Gross Profit 0.0% 2.87% 14.98%
Operating Expenses $837.0K $977.0K $1.079M
YoY Change -33.89% -9.45% 33.21%
Operating Profit -$608.0K -$628.0K -$812.0K
YoY Change -28.72% -22.66% 33.11%
Interest Expense $5.000K $24.00K $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $1.000K -$19.00K $57.00K
YoY Change -133.33% -670.0%
Pretax Income -$610.0K -$670.0K -$750.0K
YoY Change -28.24% -10.67% 25.0%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.408M -$1.279M -$754.0K
YoY Change 182.3% 69.63% 25.67%
Net Earnings / Revenue -576.08% -222.43% -249.67%
Basic Earnings Per Share
Diluted Earnings Per Share -$308.1K -$408.5K -$614.8K
COMMON SHARES
Basic Shares Outstanding 17.99M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q3 2013 Q2 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $170.0K $300.0K $990.0K
YoY Change -54.05% -69.7% -42.11%
Cash & Equivalents $170.0K $300.0K $990.0K
Short-Term Investments
Other Short-Term Assets $37.00K $70.00K $90.00K
YoY Change -26.0% -22.22% -10.0%
Inventory $291.0K $147.0K $270.0K
Prepaid Expenses
Receivables $100.0K $360.0K $890.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $600.0K $870.0K $2.240M
YoY Change -66.29% -61.16% -17.95%
LONG-TERM ASSETS
Property, Plant & Equipment $9.000K $12.00K $20.00K
YoY Change -55.0% -40.0% -66.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.947M $2.000M $2.090M
YoY Change -9.86% -4.31%
Total Long-Term Assets $1.956M $2.012M $2.110M
YoY Change -10.28% -4.64% 3416.67%
TOTAL ASSETS
Total Short-Term Assets $600.0K $870.0K $2.240M
Total Long-Term Assets $1.956M $2.012M $2.110M
Total Assets $2.556M $2.882M $4.350M
YoY Change -35.45% -33.75% 55.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.065M $786.0K $360.0K
YoY Change 83.62% 118.33% -21.74%
Accrued Expenses $183.0K $200.0K $170.0K
YoY Change 1.67% 17.65% 70.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.950M $1.689M $2.440M
YoY Change -29.09% -30.78% 328.07%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $180.0K $350.0K $1.010M
YoY Change -79.55% -65.35%
Total Long-Term Liabilities $180.0K $350.0K $1.010M
YoY Change -79.55% -65.35%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.950M $1.689M $2.440M
Total Long-Term Liabilities $180.0K $350.0K $1.010M
Total Liabilities $2.126M $2.041M $3.450M
YoY Change -41.43% -40.84% 505.26%
SHAREHOLDERS EQUITY
Retained Earnings -$110.3M -$107.9M
YoY Change
Common Stock $18.00K $18.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $430.0K $841.0K $900.0K
YoY Change
Total Liabilities & Shareholders Equity $2.556M $2.882M $4.350M
YoY Change -35.45% -33.75% 55.91%

Cashflow Statement

Concept 2013 Q3 2013 Q2 2012 Q2
OPERATING ACTIVITIES
Net Income -$2.408M -$1.279M -$754.0K
YoY Change 182.3% 69.63% 25.67%
Depreciation, Depletion And Amortization $0.00 $10.00K $40.00K
YoY Change -100.0% -75.0% 33.33%
Cash From Operating Activities -$140.0K -$1.630M -$800.0K
YoY Change -80.56% 103.75% 48.15%
INVESTING ACTIVITIES
Capital Expenditures -$670.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 -$670.0K
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $3.000M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.00K 1.680M 290.0K
YoY Change -88.89% 479.31%
NET CHANGE
Cash From Operating Activities -140.0K -1.630M -800.0K
Cash From Investing Activities 0.000 0.000 -670.0K
Cash From Financing Activities 10.00K 1.680M 290.0K
Net Change In Cash -130.0K 50.00K -1.180M
YoY Change -79.37% -104.24% 118.52%
FREE CASH FLOW
Cash From Operating Activities -$140.0K -$1.630M -$800.0K
Capital Expenditures -$670.0K
Free Cash Flow -$130.0K
YoY Change -75.93%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Period End Date
DocumentPeriodEndDate
2013-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
CY2013Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
276000 USD
CY2012Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
269000 USD
CY2013Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17984170 shares
dei Trading Symbol
TradingSymbol
NEPH
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
17985330 shares
dei Entity Registrant Name
EntityRegistrantName
NEPHROS INC
dei Entity Central Index Key
EntityCentralIndexKey
0001196298
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
us-gaap Interest Expense
InterestExpense
0 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-1368000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
2000 USD
CY2013Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
391000 USD
CY2012Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
132000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
737000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
492000 USD
CY2013Q2 us-gaap Licenses Revenue
LicensesRevenue
184000 USD
CY2012Q2 us-gaap Licenses Revenue
LicensesRevenue
170000 USD
us-gaap Licenses Revenue
LicensesRevenue
359000 USD
us-gaap Licenses Revenue
LicensesRevenue
343000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-27000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
55000 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-671000 USD
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11949824 shares
CY2013Q2 us-gaap Cash
Cash
298000 USD
CY2012Q4 us-gaap Cash
Cash
47000 USD
CY2013Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
355000 USD
CY2012Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
935000 USD
CY2013Q2 us-gaap Inventory Net
InventoryNet
147000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
312000 USD
CY2013Q2 us-gaap Other Assets Current
OtherAssetsCurrent
70000 USD
CY2012Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
1318000 USD
CY2013Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
200000 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
321000 USD
CY2013Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
703000 USD
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
707000 USD
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
109000 USD
CY2013Q2 us-gaap Assets Current
AssetsCurrent
870000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
1403000 USD
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16000 USD
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2000000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2109000 USD
CY2013Q2 us-gaap Assets
Assets
2882000 USD
CY2012Q4 us-gaap Assets
Assets
3528000 USD
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11949824 shares
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17984170 shares
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
786000 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1070000 USD
CY2013Q2 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
0 USD
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1689000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3416000 USD
CY2013Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
352000 USD
CY2012Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
707000 USD
CY2013Q2 us-gaap Liabilities
Liabilities
2041000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
4123000 USD
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
18000 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
12000 USD
CY2013Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
100191000 USD
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
96847000 USD
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
74000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
76000 USD
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-99442000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-97530000 USD
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
841000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-595000 USD
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2882000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3528000 USD
CY2013Q2 us-gaap Sales Revenue Net
SalesRevenueNet
575000 USD
CY2012Q2 us-gaap Sales Revenue Net
SalesRevenueNet
302000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
1096000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
835000 USD
CY2013Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
226000 USD
CY2012Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
35000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
421000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
257000 USD
CY2012Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-54000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-673000 USD
CY2013Q2 us-gaap Gross Profit
GrossProfit
349000 USD
CY2012Q2 us-gaap Gross Profit
GrossProfit
267000 USD
us-gaap Gross Profit
GrossProfit
675000 USD
us-gaap Gross Profit
GrossProfit
578000 USD
CY2013Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
259000 USD
CY2012Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
199000 USD
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
483000 USD
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
344000 USD
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-812000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-1840000 USD
CY2013Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
CY2012Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
CY2013Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-19000 USD
CY2012Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
57000 USD
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-754000 USD
us-gaap Net Income Loss
NetIncomeLoss
-1912000 USD
us-gaap Net Income Loss
NetIncomeLoss
-1311000 USD
CY2013Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
58000 USD
CY2012Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
42000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
114000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
44000 USD
CY2013Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
660000 USD
CY2012Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
838000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1918000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1558000 USD
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
977000 USD
CY2012Q2 us-gaap Operating Expenses
OperatingExpenses
1079000 USD
us-gaap Operating Expenses
OperatingExpenses
2515000 USD
us-gaap Operating Expenses
OperatingExpenses
1946000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-628000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-10000 USD
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-808000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1914000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1321000 USD
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2012Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.14
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
CY2013Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14556050 shares
CY2012Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10967245 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
13289703 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10765553 shares
CY2013Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
0 USD
CY2012Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
0 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
2000 USD
CY2013Q2 us-gaap Interest Expense
InterestExpense
24000 USD
CY2012Q2 us-gaap Interest Expense
InterestExpense
0 USD
us-gaap Interest Expense
InterestExpense
47000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
229000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5000 USD
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
109000 USD
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
39000 USD
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
248000 USD
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
168000 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-3000 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
4000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-577000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1014000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-166000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
21000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-37000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-23000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-330000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
58000 USD
neph Increase Decrease In License And Supply Agreement Fee Payable
IncreaseDecreaseInLicenseAndSupplyAgreementFeePayable
-1318000 USD
neph Increase Decrease In License And Supply Agreement Fee Payable
IncreaseDecreaseInLicenseAndSupplyAgreementFeePayable
0 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-359000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-343000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-2762000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-372000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
2000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
2000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-666000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
1000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
0 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
251000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-682000 USD
CY2011Q4 us-gaap Cash
Cash
1669000 USD
CY2012Q2 us-gaap Cash
Cash
987000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
2000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
15000 USD
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
0 USD
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
1238000 USD
us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
0 USD
us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
755000 USD
neph Share Based Goods And Nonemployee Services Transaction Fair Market Value Of Options Granted
ShareBasedGoodsAndNonemployeeServicesTransactionFairMarketValueOfOptionsGranted
273000 USD
neph Share Based Goods And Nonemployee Services Transaction Fair Market Value Of Options Granted
ShareBasedGoodsAndNonemployeeServicesTransactionFairMarketValueOfOptionsGranted
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
659000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
3010000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
356000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
1300000 USD
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
0 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
239000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
356000 USD
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
1300000 USD
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
0 USD
neph Noncash Warrant Inducement
NoncashWarrantInducement
14000 USD
neph Noncash Warrant Inducement
NoncashWarrantInducement
0 USD
neph Restricted Stock Shares Isuued To Settle Liability
RestrictedStockSharesIsuuedToSettleLiability
77000 USD
neph Restricted Stock Shares Isuued To Settle Liability
RestrictedStockSharesIsuuedToSettleLiability
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2771000 USD
CY2013Q1 us-gaap Senior Notes
SeniorNotes
1300000 USD
CY2013Q1 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.12 pure
CY2013Q1 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2013-08-04
CY2013Q2 neph Debt Instrument Rights Offering Description
DebtInstrumentRightsOfferingDescription
2013-05-17
CY2013Q2 neph Sourcing And Transaction Fee Percentage
SourcingAndTransactionFeePercentage
0.08 pure
CY2013Q2 neph Sourcing And Transaction Fee
SourcingAndTransactionFee
104000 USD
CY2013Q2 neph Legal Fees And Other Expenses
LegalFeesAndOtherExpenses
100000 USD
CY2013Q2 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
1400000 USD
CY2013Q2 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
1300000 USD
CY2013Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3000000 USD
CY2013Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
46800 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
176875 shares
us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
96000 USD
CY2013Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
926000 USD
neph Expected Recognition Of Unrecognized Compensation Costs Due In Current Year
ExpectedRecognitionOfUnrecognizedCompensationCostsDueInCurrentYear
0.2 pure
neph Expected Recognition Of Unrecognized Compensation Costs Due In One Year
ExpectedRecognitionOfUnrecognizedCompensationCostsDueInOneYear
0.36 pure
neph Expected Recognition Of Unrecognized Compensation Costs Due In Two Years
ExpectedRecognitionOfUnrecognizedCompensationCostsDueInTwoYears
0.34 pure
CY2013Q2 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
310699 shares
CY2013Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
69000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y8M12D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Restricted Stock Award Forfeitures Dividends
RestrictedStockAwardForfeituresDividends
188000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
119000 USD
neph Expected Recognition Of Unrecognized Compensation Costs Due In Three Years
ExpectedRecognitionOfUnrecognizedCompensationCostsDueInThreeYears
0.09 pure
neph Expected Recognition Of Unrecognized Compensation Costs Due In Four Years
ExpectedRecognitionOfUnrecognizedCompensationCostsDueInFourYears
0.01 pure
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
206000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
168000 USD
CY2012 neph Restricted Stock Shares Isuued To Settle Liability
RestrictedStockSharesIsuuedToSettleLiability
77000 USD
CY2011Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
0.40
CY2011Q1 neph Warrants Exercised
WarrantsExercised
14879708 shares
CY2011Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
687793 shares
CY2013Q2 neph Incremental Fair Value Of Inducement
IncrementalFairValueOfInducement
14000 USD
CY2011Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
206000 USD
neph Warrants Exercised
WarrantsExercised
1769369 shares
CY2013Q2 us-gaap Inventory Gross
InventoryGross
423000 USD
CY2012Q4 us-gaap Inventory Gross
InventoryGross
581000 USD
CY2013Q2 us-gaap Accumulated Amortization Of Other Deferred Costs
AccumulatedAmortizationOfOtherDeferredCosts
251000 USD
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
109000 USD
CY2013Q2 neph Finite Lived Intangible Assets Amortization Expense Years Two And Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearsTwoAndThree
210000 USD
neph Royalty Rate
RoyaltyRate
0.03 pure
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
105000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2000 USD
neph Stock Issued During Period Value Shareholder Rights Offering
StockIssuedDuringPeriodValueShareholderRightsOffering
2771000 USD
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
240000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
325000 USD
neph Adjustments To Additional Paid In Capital Warrant Incremental Fair Value Of Inducement
AdjustmentsToAdditionalPaidInCapitalWarrantIncrementalFairValueOfInducement
14000 USD

Files In Submission

Name View Source Status
0001144204-13-045172-index-headers.html Edgar Link pending
0001144204-13-045172-index.html Edgar Link pending
0001144204-13-045172.txt Edgar Link pending
0001144204-13-045172-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
neph-20130630.xml Edgar Link completed
neph-20130630.xsd Edgar Link pending
neph-20130630_cal.xml Edgar Link unprocessable
neph-20130630_def.xml Edgar Link unprocessable
neph-20130630_lab.xml Edgar Link unprocessable
neph-20130630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R28.xml Edgar Link unprocessable
R29.htm Edgar Link pending
R29.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R30.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R31.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending
v348930_10q.htm Edgar Link pending
v348930_ex10-1.htm Edgar Link pending
v348930_ex10-2.htm Edgar Link pending
v348930_ex31-1.htm Edgar Link pending
v348930_ex32-1.htm Edgar Link pending